TipHub

₹30.01

▼ -0.01 -0.03%

29 Jul 2026

BSE Listed

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-06-30

Pharmaids Pharmaceuticals Ltd. (524572)

Volume: 760Avg Vol 1W: 2,562Avg Vol 1M: 11,76052W Range:₹25.6₹68
BSE www.pharmaids.com AI Report
Key Ratios
Checked just now
Market Cap₹108 Cr
Current Price₹30.01
Previous Close₹30.02
High / Low (52w)₹68 / ₹25.6
Volume760
Avg Vol (1W)2,562
Avg Vol (1M)11,760
Stock P/E—
Book Value₹13.51
Dividend Yield0%
ROE-29.76%
ROA-13.26%
Revenue (TTM)—
Revenue Growth—
Profit Margin-42.04%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹0
P/B2.26
Debt / Equity0.36
50 DMA₹31.48
200 DMA₹38.48
Day change-0.03%
SurveillanceLT-ASM · ASM 1
Price Chart
₹30.01▼ 52.96% · 1Y
₹66₹271.2L
2025-07-29
2026-07-29

20-day avg volume: 9K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 224% YoY.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹7 Cr₹9 Cr₹5 Cr₹7 Cr
EBITDA₹-4 Cr₹-3 Cr₹-4 Cr₹-4 Cr₹-6 Cr₹-6 Cr₹-3 Cr₹-1 Cr
Net Profit₹-3 Cr₹-2 Cr₹-2 Cr₹-4 Cr₹-5 Cr₹-3 Cr₹-2 Cr₹-2 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1 Cr₹1 Cr₹0 Cr₹20 Cr₹1 Cr₹6 Cr₹1 Cr₹3 Cr
EBITDA₹-1 Cr₹-2 Cr₹-2 Cr₹-15 Cr₹-5 Cr₹-4 Cr₹-4 Cr₹-1 Cr
Net Profit₹-1 Cr₹-2 Cr₹-3 Cr₹-11 Cr₹-4 Cr₹-2 Cr₹-3 Cr₹-1 Cr
EPS———-3.05————
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹11 Cr₹25 Cr₹91 Cr₹120 Cr
Total Liabilities₹2 Cr₹2 Cr₹21 Cr₹65 Cr
Equity₹9 Cr₹22 Cr₹70 Cr₹55 Cr
Total Debt————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹-4 Cr₹-11 Cr₹-14 Cr
Investing₹0 Cr₹-5 Cr₹-75 Cr₹-12 Cr
Financing₹0 Cr₹21 Cr₹78 Cr₹23 Cr
Free Cash Flow₹0 Cr₹-4 Cr₹-11 Cr₹-14 Cr
Shareholding
Promoter 32.99% Institutions 0% Public 67.01%
Efficiency & Working Capital
ROCE-21%
Interest Coverage-7.2
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-06-30

Promoter33%
FII0%
DII0%
Institutions0%
Public67%
Promoter Pledge0%
No. of Shareholders8,632
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Apr 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters9.3%5.6%5.6%5.6%5.2%5.2%5.2%5.1%33%33%33%33%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public90.7%94.4%94.4%94.4%94.8%94.8%94.8%94.9%67%67%67%67%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders7,2817,5677,5677,5948,0508,3498,2208,0268,0278,2888,4068,632
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Shankarappa Nagaraja Vinaya BabuShareholding of Promoter and Promoter Group28.5%1.01 Cr
Shreedhara ShettyPublic Shareholding14.5%51,25,621
Gokaram Ramkrishna BalajiPublic Shareholding8%28,17,314
Smitha Shetty Sachit ShettyPublic Shareholding7.7%27,22,258
Tumkur Trade Center Private LimitedShareholding of Promoter and Promoter Group4.5%15,68,000
Venkata Rao SadhanalaPublic Shareholding4.3%15,23,271
Makam SreevalliPublic Shareholding2.2%7,80,242
Venu Madhava KaparthyPublic Shareholding2%7,17,281
Venkatesh MahendraPublic Shareholding1.2%4,38,097
Kant RaoShareholding of Promoter and Promoter Group0%7,300
Activin Chemicals And Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group0%0
Koye Lifesciences Private LimitedShareholding of Promoter and Promoter Group0%0
Moki PartnersShareholding of Promoter and Promoter Group0%0
Moki Financial ServicesShareholding of Promoter and Promoter Group0%0
B. VenkatswamyShareholding of Promoter and Promoter Group0%1,070
Hosaangadi Nithyananda SoumyaShareholding of Promoter and Promoter Group0%0
LalithammaShareholding of Promoter and Promoter Group0%0
Melanahally Shankarappa NagarajuShareholding of Promoter and Promoter Group0%0
S N Veena RaniShareholding of Promoter and Promoter Group0%0
Kishan Raj VShareholding of Promoter and Promoter Group0%0
V. MonishaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Shankarappa Nagaraja Vinaya BabuChairman(Non Exe)&Dir(Non-Ind)2025
P N VijayIndependent Non Exe. Director2025
M Sudheer AnandIndependent Non Exe. Director2025
Methuku NageshIndependent Non Exe. Director2025
Shreedhara ShettyNon-Exec & Non-Independent Dir2025
Balagangadhara BcNon Executive Director / Chief Financial Officer2025
Prasanna Subramanya BhatCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10453535
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202511002911—
2025800261045
2025200315
Insider / Designated-Person Trades

9 recent disclosure(s)

SHANKARAPPA NAGARAJA VINAYA BABU RevisedAcquisition · 1,00,000
MALIEMADOM RAMASWAMY IYER MAHADEVANDisposal · 4,000
Shankarappa Nagaraja Vinaya BabuAcquisition · 27,10,210
MALIEMADOM RAMASWAMY IYER MAHADEVANDisposal · 1,50,000
PRASANNA SUBRAMANYA BHATDisposal · 50,002
BALAGANGADHARA BIDANAGERE CHANNATHIMMAIAHDisposal · 4,50,000
Substantial Acquisitions (SAST)

12 disclosure(s)

Off Market20/12/2024 · 18,20,854
Pref. Allotment02/03/2024 · 15,68,000
Pref. Allotment02/03/2024 · 19,44,446
Pref. Allotment02/03/2024 · 38,88,857
Pref. Allotment02/03/2024 · 27,22,258
Off Market / Inter se transfer22/11/2023 · 44,000
Company Information
Incorporated1989
ChairmanShankarappa Nagaraja Vinaya Babu
AuditorPPKG & Co
Investor Email[email protected]
🌐 www.pharmaids.com ↗

📍 4-4-211/212/3 1st Floor, Inderbagh Sulthan Bazar, Hyderabad, Telangana, 500095

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Bhaskar Agrochemicals Ltd.Sukhjit Starch & ChemicalsSharma East India Hosp and Medical Research Ltd.Neuland LaboratoriesGayatri Bioorganics Ltd.Poddar PigmentsVivid Global Industries LimitedPriya Ltd.Tirupati Starch & Chemicals Ltd.Hemo Organic LimitedJaysynth Orgochem LimitedAeonx Digital Technology Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search